Published in Women's Health Weekly, October 7th, 2004
Reporting in the September 15, 2004, issue of Cancer Research, Fox Chase Cancer Center, Philadelphia, researchers explain that the new method targets hypermethylation, one mechanism used by cancer cells to turn off genes that protect against tumor development.
When these tumor-suppressor genes are inactivated by hypermethylation, they cannot do their job, which then allows cancer cells to develop. This research marks the first time hypermethylation has been examined for the detection of ovarian cancer.
Fox Chase molecular biologist Paul Cairns, PhD,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly